Log in
Enquire now

List of Metabolic Solutions Development Company patents

List of Metabolic Solutions Development Company patents
List of NantEnergy patents
List of The Swatch Group patents
List of Rapt Industries patents
List of funding rounds for DriveWealth (company)
List of founders from Zagreb
Patents where
Current Assignee
Name
is
‌
Metabolic Solutions Development Company
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8937182 Synthesis for thiazolidinedione compounds

Patent 8937182 was granted and assigned to Metabolic Solutions Development Company on January, 2015 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8937182
January 20, 2015
‌
US Patent 8946435 Synthesis for thiazolidinedione compounds

Patent 8946435 was granted and assigned to Metabolic Solutions Development Company on February, 2015 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8946435
February 3, 2015
‌
US Patent 9562012 PPAR-sparing compounds for the treatment of metabolic diseases

Patent 9562012 was granted and assigned to Metabolic Solutions Development Company on February, 2017 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
9562012
February 7, 2017
‌
US Patent 8933240 Synthesis for thiazolidinedione compounds

Patent 8933240 was granted and assigned to Metabolic Solutions Development Company on January, 2015 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8933240
January 13, 2015
‌
US Patent 9126959 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Patent 9126959 was granted and assigned to Metabolic Solutions Development Company on September, 2015 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
9126959
September 8, 2015
‌
US Patent 8629159 Thiazolidinedione analogues

Patent 8629159 was granted and assigned to Metabolic Solutions Development Company on January, 2014 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8629159
January 14, 2014
‌
US Patent 9155729 Thiazolidinedione analogues

Patent 9155729 was granted and assigned to Metabolic Solutions Development Company on October, 2015 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
9155729
October 13, 2015
‌
US Patent 8067450 Thiazolidinedione analogues for the treatment of metabolic diseases

Patent 8067450 was granted and assigned to Metabolic Solutions Development Company on November, 2011 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8067450
November 29, 2011
‌
US Patent 8912335 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Patent 8912335 was granted and assigned to Metabolic Solutions Development Company on December, 2014 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8912335
December 16, 2014
‌
US Patent 8895748 Synthesis for thiazolidinedione compounds

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8895748
November 25, 2014
‌
US Patent 8304441 Thiazolidinedione analogues for the treatment of metabolic diseases

Patent 8304441 was granted and assigned to Metabolic Solutions Development Company on November, 2012 by the United States Patent and Trademark Office.

‌
Metabolic Solutions Development Company
United States Patent and Trademark Office
United States Patent and Trademark Office
8304441
November 6, 2012
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us